United Therapeutics: Rothblatt trust sells 9,500 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
United Therapeutics (UTHR) Chairperson & CEO Martine A. Rothblatt reported that a family trust in which she shares investment power exercised 9,500 options at $117.76 per share and acquired 9,500 common shares on November 17, 2026. The trust sold 9,500 shares that day in 11 reported lots; weighted-average prices included $576.1626 for 373 shares and $586.4854 for 240 shares.
The exercise and sales were under a pre-arranged Rule 10b5-1 plan adopted November 7, 2025. The report lists 5,410 options after the exercise, 40,513 common shares held directly, and 166 shares held by Rothblatt’s spouse.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F17, F18 | 9,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 9,500 | $117.76 | $1.12M |
| Sale | Common Stock F1, F3, F2 | 373 | $576.1626 | $215K |
| Sale | Common Stock F1, F4, F2 | 1,017 | $577.1382 | $587K |
| Sale | Common Stock F1, F5, F2 | 1,763 | $578.1728 | $1.02M |
| Sale | Common Stock F1, F6, F2 | 1,127 | $579.1086 | $653K |
| Sale | Common Stock F1, F7, F2 | 955 | $580.1316 | $554K |
| Sale | Common Stock F1, F8, F2 | 1,112 | $581.1777 | $646K |
| Sale | Common Stock F1, F9, F2 | 449 | $582.5741 | $262K |
| Sale | Common Stock F1, F10, F2 | 2,004 | $583.2153 | $1.17M |
| Sale | Common Stock F1, F11, F2 | 381 | $584.2163 | $223K |
| Sale | Common Stock F1, F12, F2 | 79 | $585.2708 | $46K |
| Sale | Common Stock F1, F13, F2 | 240 | $586.4854 | $141K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock F14 | -- | -- | -- |
| Holding | Common Stock F15 | -- | -- | -- |
| Holding | Common Stock F16 | -- | -- | -- |
Footnotes (18)
- F1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10. This transaction was executed in multiple trades at prices ranging from $582.86 to $583.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. This transaction was executed in multiple trades at prices ranging from $583.86 to $584.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12. This transaction was executed in multiple trades at prices ranging from $585.01 to $585.525. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13. This transaction was executed in multiple trades at prices ranging from $586.48 to $586.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F15. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F16. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F17. These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F18. Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3. This transaction was executed in multiple trades at prices ranging from $575.68 to $576.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $576.68 to $577.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $577.68 to $578.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $578.68 to $579.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $579.70 to $580.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $580.72 to $581.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $581.84 to $582.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Key Terms
10b5-1 trading plan regulatory
weighted average price financial
stock options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many UTHR options did Rothblatt’s family trust exercise?
What are the terms of Martine A. Rothblatt’s UTHR trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.